Table 3 Maximum reimbursable price when Mia®’s specificity is at 99% or sensitivity at 79.7%

From: Cost-effectiveness requirements for implementing artificial intelligence technology in the Women’s UK Breast Cancer Screening service

Intervention

Price per scan

Cost

QALYs

Incremental Costs*

Incremental QALYs*

NMB

INMB

Result**

Mia® Spec 99.0% Sens 75.1%

4.72

£3,718.81

16.4230

−£7.90

0.00034

£324,741

£14.68

Mia® dominates

Mia® Spec 97.3% Sens 79.8%

4.72

£3,722.20

16.4225

−£4.51

−0.00014

£324,728

£1.73

Mia® is cost-effective but small difference indicates likely indifferent

Standard practice Spec 97.0% Sens 76.1%

-

£3,726.71

16.4227

  

£324,727

  
  1. *Mia® interventions are compared against standard practice.
  2. **Dominates indicates that Mia® is cheaper and more effective.
  3. Source data are provided as a Source Data file.
Back to article page